SUSAR and Line Listings (only applicable to SAHPRA approved medication research)
Reporting of SUSARs (Suspected Unexpected Serious Adverse Reactions) six-monthly as part of the Progress Report
- About Us
- Research
- Application for ethics review
- Post Approval Submissions
- Resources
- Contact us